CTLA4 and primitive neuroectodermal tumor: For instance, experimental induction of TLS with LIGHT-VTP therapy renders PNET and Lewis lung carcinoma (LLC) sensitive to ICB targeting cytotoxic T-lymphocyte-associated protein 4 (CTLA-4) and PD-1.